← back to search

Jill E. Stopfer

Dana-Farber Cancer Institute · US
Area of research
Genetics · Pathology and Forensic Medicine
Research interest
Research interests include BRCA gene mutations in cancer, Genetic factors in colorectal cancer, Genetics, Bioinformatics, and Biomedical Research, and Ethics in Clinical Research.
h-index
39
citations
4,413
works
168
NIH funding
primary concept
email

Recent publications

A Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study
Gastroenterology 2024cited by 17position: middledoi
Inherited TP53 Variants and Risk of Prostate Cancer
European Urology 2021cited by 90position: middledoi
A Rare <i>TP53</i> Mutation Predominant in Ashkenazi Jews Confers Risk of Multiple Cancers
Cancer Research 2020cited by 28position: middledoi
Research participants’ experiences with return of genetic research results and preferences for web‐based alternatives
Molecular Genetics & Genomic Medicine 2019cited by 31position: middledoi
Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results
JNCI Journal of the National Cancer Institute 2018cited by 47position: middledoi
Preferences for in‐person disclosure: Patients declining telephone disclosure characteristics and outcomes in the multicenter Communication Of GENetic Test Results by Telephone study
Clinical Genetics 2018cited by 29position: middledoi
Utilizing Remote Real-Time Videoconferencing to Expand Access to Cancer Genetic Services in Community Practices: A Multicenter Feasibility Study
Journal of Medical Internet Research 2016cited by 110position: middledoi
Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing
Genetics in Medicine 2015cited by 68position: middledoi
Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility
Genetics in Medicine 2014cited by 87position: middledoi
Biallelic Deleterious <i>BRCA1</i> Mutations in a Woman with Early-Onset Ovarian Cancer
Cancer Discovery 2012cited by 147position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Susan M. Domchek · University of Gothenburg4 papers (2012–2019)Angela R. Bradbury · University of Pennsylvania3 papers (2015–2019)Linda Patrick‐Miller · University of Chicago3 papers (2015–2019)Katherine L. Nathanson · Pennsylvania Hospital3 papers (2012–2019)Brian L. Egleston · Fox Chase Cancer Center3 papers (2015–2019)Jacquelyn Powers · University of Rochester2 papers (2015–2019)Kara N. Maxwell · Philadelphia VA Medical Center2 papers (2015–2019) · 2 papers (2015–2016)Dominique Fetzer · California University of Pennsylvania2 papers (2016–2019) · 2 papers (2015–2016)Laura DiGiovanni · University of Illinois Chicago2 papers (2015–2019)Jamie Brower · Center for Cancer Research2 papers (2015–2019)Jessica M. Long · Wake Forest University2 papers (2015–2019) · 1 papers (2019–2019)Fergus J. Couch · Mayo Clinic1 papers (2012–2012)Evelyn Stevens · Thomas Jefferson University1 papers (2016–2016)Sarah A. Walser · Pennsylvania State University1 papers (2019–2019)Troy E. Messick · The Wistar Institute1 papers (2012–2012)William D. Foulkes · McGill University Health Centre1 papers (2012–2012) · 1 papers (2015–2015)